Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinoma.

L M Weiner; E Harvey; K Padavic-Shaller; J K Willson; C Walsh; F LaCreta; M B Khazaeli; J M Kirkwood; D G Haller

doi:10.1097/00002371-199302000-00005

Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinoma.

Identifier:nobleid.org/w1/20260515/ADE83973

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ADE83973.svg?ark=w1%2F20260515%2FADE83973)](https://nobleid.org/work/w1/20260515/ADE83973)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinoma.

Identifier:nobleid.org/w1/20260515/ADE83973

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ADE83973.svg?ark=w1%2F20260515%2FADE83973)](https://nobleid.org/work/w1/20260515/ADE83973)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work